- Home
- VOC vs PRLD Comparison
VOC vs PRLD Comparison
Compare VOC & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- PRLD
- Stock Information
- Founded
- VOC 2010
- PRLD 2016
- Country
- VOC United States
- PRLD United States
- Employees
- VOC N/A
- PRLD N/A
- Industry
- VOC Oil & Gas Production
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- VOC Energy
- PRLD Health Care
- Exchange
- VOC Nasdaq
- PRLD Nasdaq
- Market Cap
- VOC 51.3M
- PRLD 44.0M
- IPO Year
- VOC 2011
- PRLD 2020
- Fundamental
- Price
- VOC $2.84
- PRLD $0.84
- Analyst Decision
- VOC
- PRLD Strong Buy
- Analyst Count
- VOC 0
- PRLD 2
- Target Price
- VOC N/A
- PRLD $4.50
- AVG Volume (30 Days)
- VOC 116.3K
- PRLD 121.8K
- Earning Date
- VOC 01-01-0001
- PRLD 08-15-2025
- Dividend Yield
- VOC 22.16%
- PRLD N/A
- EPS Growth
- VOC N/A
- PRLD N/A
- EPS
- VOC 0.63
- PRLD N/A
- Revenue
- VOC $11,917,424.00
- PRLD $7,000,000.00
- Revenue This Year
- VOC N/A
- PRLD N/A
- Revenue Next Year
- VOC N/A
- PRLD N/A
- P/E Ratio
- VOC $4.51
- PRLD N/A
- Revenue Growth
- VOC N/A
- PRLD N/A
- 52 Week Low
- VOC $2.44
- PRLD $0.61
- 52 Week High
- VOC $5.69
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- VOC 40.09
- PRLD 48.35
- Support Level
- VOC $2.78
- PRLD $0.82
- Resistance Level
- VOC $3.48
- PRLD $0.91
- Average True Range (ATR)
- VOC 0.13
- PRLD 0.09
- MACD
- VOC -0.05
- PRLD 0.00
- Stochastic Oscillator
- VOC 6.37
- PRLD 28.00
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.